Response to comments on the Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the scientific substantiation of a health claim related to Bimuno® GOS and reducing gastro-intestinal discomfort pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following a request from the European Commission, EFSA was asked to address the scientific comments received on the Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the scientific substantiation of a health claim related to Bimuno^® GOS and reducing gastro-intestinal discomfort pursuant to Article 13(5) of Regulation (EC) No 1924/2006. Comments submitted to EFSA via the European Commission Services originated from the applicant (Clasado Limited). The comments received were related to the claimed effect, the outcome measures used to assess the claimed effect and the assessment of the studies submitted to substantiate the health claim. EFSA has reviewed and shared these comments with the chair of the NDA Panel and the chair of the NDA Working Group on Claims. The comments received do not require any change to the conclusions of the NDA Panel.